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Heshouwu (HSW), the dry roots of Polygonummultiflorum, a classical traditional Chinese
medicine is used as a tonic for a wide range of conditions, particularly those associated
with aging. However, it tends to be taken overdose or long term in these years, which
has resulted in liver damage reported in many countries. In this study, the indicative
roles of nine bile acids (BAs) were evaluated to offer potential biomarkers for HSW
induced liver injury. Nine BAs including cholic acid (CA) and chenodeoxycholic acid
(CDCA), taurocholic acid (TCA), glycocholic acid (GCA), glycochenodeoxycholic acid
(GCDCA), deoxycholic acid (DCA), glycodeoxycholic acid (GDCA), ursodeoxycholic acid
(UDCA), and hyodeoxycholic acid (HDCA) in rat bile and serum were detected by a
developed LC-MS method after 42 days treatment. Partial least square-discriminate
analysis (PLS-DA) was applied to evaluate the indicative roles of the nine BAs, and
metabolism of the nine BAs was summarized. Significant change was observed for
the concentrations of nine BAs in treatment groups compared with normal control;
In the PLS-DA plots of nine BAs in bile, normal control and raw HSW groups were
separately clustered and could be clearly distinguished, GDCA was selected as the
distinguished components for raw HSW overdose treatment group. In the PLS-DA plots
of nine BAs in serum, the normal control and raw HSW overdose treatment group were
separately clustered and could be clearly distinguished, and HDCA was selected as the
distinguished components for raw HSW overdose treatment group. The results indicated
the perturbation of nine BAs was associated with HSW induced liver injury; GDCA in bile,
as well as HDCA in serum could be selected as potential biomarkers for HSW induced
liver injury; it also laid the foundation for the further search on the mechanisms of liver
injury induced by HSW.
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Introduction
Heshouwu (HSW), the dry roots of Polygonum multiflorum,
has been used in oriental counties for centuries, and is gaining
popularity for treatment of many ailments, particularly those
associated with aging (Park et al., 2011). Traditional Chinese
herbal medicine ordinarily recommended the use of herbs in
complex formulas, however both of them were considered as
non-toxic medicine and were always taken as a single. In 2002,
raw HSW and processed HSW were authorized as health food
additive by the government of People’s Republic of China. Then
both of them were taken as tonic in varies forms in many
countries (Yu et al., 2011; Dong et al., 2014).
However, hepatic adverse effect was constantly reported since
1990s in China, Canada, Korea, Japan, Britain, Italy, Australia,
and other countries (Park et al., 2001; Lei et al., 2015), and
supervisions of usage of HSWwere conducted by drug regulatory
agencies of Canada, British, Australia, and China, due to
continually adverse effect reports. Therefore, detection of liver
injury induced by HSW remains an issue to be tackled.
Currently, assessment for HSW induced liver injury
relies primarily on histopathology and clinical chemistry
based on a panel of serum biomarkers, including aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
alkaline phosphatase(ALP), γ-glutamyltransferase (GGT) and
total bilirubin (TBil) (Park et al., 2001; Jung et al., 2011; Dong
et al., 2014). However, histopathological diagnosis only offers a
destination indicator and may lack sufficient sensitivity. Changes
with the common serum biomarkers may be contributed by
factors other than HSW induced liver injury (Ennulat et al.,
2010). These limitations have prompted the discovery of new
biomarkers for HSW induced liver injury diagnosis, which will
complement the current methodology. Therefore, detection of
bile acids (BAs) might be an applicable approach in addressing
detection of liver injury induced by HSW.
BAs are generated in the liver and accumulate in blood during
liver injury, and have been proposed as biomarkers for liver
injury and dysfunction (Reichel and Sauerbruch, 1995; Neghab
and Stacey, 2000; Hofmann and Hagey, 2008). Furthermore,
there were reports that identified perturbation of BA homeostasis
as a common and early event of drug induced liver injury
by diverse hepatotoxins (Yamazaki et al., 2013). Numerous BA
species have been detected in mammals, and the primary BAs,
cholic acid (CA) and chenodeoxycholic acid (CDCA), and their
amino acid conjugate species and deoxycholic acids were most
abundant in mice and man (de Aguiar Vallim et al., 2013).
In this study, nine BAs that were abundant in mice and
man were simultaneously determined and evaluated for HSW-
induced liver injury. Based on our previous study on the toxic
dose of HSW, dosage and duration of administration time were
determined (Li et al., 2013; Tu et al., 2015). LC-MS method
was applied to quantified nine metabolites in rat bile and
serum samples collected after the last administration, including
CA, CDCA, taurocholic acid (TCA), glycocholic acid (GCA),
glycochenodeoxycholic acid (GCDCA), deoxycholic acid (DCA),
glycodeoxycholic acid (GDCA), ursodeoxycholic acid (UDCA),
and hyodeoxycholic acid (HDCA). Chlorpromazine was selected
as positive control as intrahepatic cholestasis is manifested in
liver injury of reported studies (Regal et al., 1987). The indicative
roles of the nine BAs were evaluated by partial least square-
discriminate analysis (PLS-DA), and metabolism of the nine BAs
was summarized, this study offered potential biomarkers for liver
injury induced by HSW, which might be conductive to HSW’s
clinical application, and provide a basis for further mechanism
study of liver injury induced by HSW.
Materials and Methods
Chemicals, Reagents, and Materials
Raw HSW (10050904) and processed HSW (10122402) were
purchased from the Lvye pharmaceutical co., ltd. (Beijing,
China), and the materials were identified by Professor Xiao-he
Xiao (PLA Institute of Chinese Material Medical, 302 Hospital of
People’s Liberation Army, Beijing, 100039, PR China). According
to Chinese pharmacopeia (China Pharmacopoeia Committee,
2010), the quality of raw HSW and processed HSW were
controlled. Chlorpromazine was purchased from Sigma (St.
Quentin Fallavier, France).
Acetonitrile, methanol, formic acid were from Fisher
Chemicals (Pittsburg, PA, USA). Ammonium acetate of
HPLC grade was from Fluka (Buchs, Switzerland). Water was
purified using a Milli-Q water purification system (Millipore,
Bedford, MA, USA). Standards references of cholic acid (CA),
chenodeoxycholic acid (CDCA), deoxycholic acid (DCA),
glycochenodeoxycholic acid (GCDCA), hyodeoxycholic acid
(HDCA), ursodeoxycholic acid (UDCA), taurocholic acid
(TCA), glycocholic acid (GCA), glycodeoxycholic acid (GDCA),
and bendrofluazide (IS) were purchased from the Control of
Pharmaceutical and Biological Products (Beijing, China). Their
purities were above 98%.
Preparation of herb extract: the dried and powdered raw
HSW (1 kg) and processed HSW (1 kg) were respectively
extracted five times by macerating with 6 L of 75% ethanol
for 48 h each time. All the solvents were collected and then
removed under reduced pressure, and HPLC was applied
to multicomponent quantification of the extracts, which was
depicted in Supplementary Material. Furthermore, a LC-MS
method has been applied to analysis components of extracts
of raw and processing HSW, giving more information about
difference between raw and processing HSW, the methods and
results (Figure S1 and Table S1) were depicted in Supplementary
Material. Then, the extracts of raw HSW and processed HSW
were redissolved with water to produce equivalent to 8 g of crude
drug/mL, respectively.
Animals, Administration, and Sample Collection
Male Sprague-Dawley (SD) rats (160± 20 g) were obtained from
the Academy of Military Medical Science (Beijing, China). All
the animals were kept under the same laboratory conditions of
temperature from 20 to 22◦C and were given access to standard
laboratory chow and tap water. The procedures involving animals
and their care conform to the Guiding Principles for the Care
and Use of Laboratory Animals of China. Prior to treatment,
the rats were kept in the breeding room for 3 days and were
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randomly divided into four groups (n = 6 for each group). Group
I was orally administrated with 5.0mL of water everyday as the
vehicle. Group II, III, and IV were orally administrated with
50.0 g/kg/day of processed HSW extract, 50.0 g/kg/day of raw
HSW extract and 0.1 g/kg/day of chlorpromazine respectively
for 42 days. Retro-orbital blood samples were collected into
tubes every week for serum biochemical indicators detection.
After last administration, 1.5mL of blood sample was collected
at time point of 1, 2, 3, and 4 h. The blood samples were
immediately centrifuged at 3000 rpm (4◦C) for 15min to separate
the serum. The serum collected at different time point from the
same rat was mixed. Bile was collected after finishing the blood
collection. The rat was anesthetized using midazolam (5mg/kg)
and the common bile duct was cannulated with a 30-gauge
needle attached to PE-10 tubing. Bile was collected from the
cannula for 4 h at 15-min intervals. The bile samples of one
rat were mixed. The mixed samples were sub-aliquoted into the
sample containers to be stored at 80◦C until analysis. After bile
sample collection, rats were sacrificed, and the change of liver
histopathology was assessed.
Analysis of Liver Injury Biomarkers
LC-MS Conditions
A Shimadzu (Japan) LC–MS 20AD system was carried out in
the assay. The chromatographic separation was achieved on
a Ulimate C18 column (150mm × 4.6mm, 5µm). Methanol
(containing 0.1% fomic acid, solvent A)—water (containing
1mmol ammonium acetate and 0.1% fomic acid, solvent B)
system was used as the mobile phase. The gradient elution
condition was optimized as follows: linear gradient from 70 to
80% A (0–3min), 80 to 90% A (3–8min), 90 to 95% A (8–
8.5min), 95 to 100% A (8.5–14.4min) then back to 70% A in
0.1min, and maintain at 70% A for 5.5min. The flow rate of
the mobile phase was set at 0.7mL/min, and 25% of the eluent
was splitted into the inlet of the mass spectrometer. The column
and autosampler temperature were maintained at 40◦C and 4◦C,
respectively. The analytes and IS were equipped with electrospray
ionization (ESI) interface in negative ion mode. The quantitative
analysis was conducted by MRM at m/z 407.2→ 407.2 for CA,
m/z 391.2→ 391.2 for CDCA,m/z 391.2→ 391.2 for DCA,m/z
464.2→ 74.0 for GCA,m/z 448.2→ 74.0 for GCDCA,m/z 448.2
→ 74.0 for GDCA, m/z 391.3→ 391.3 for HDCA, m/z 514.2→
79.8 for TCA, m/z 391.2→ 391.2 for UDCA, and m/z 419.95→
419.95 for IS. The optimum source conditions were set as follows:
nebulizing gas of 1.2 L/min; heat block temperature of 200◦C;
CDL temperature of 350◦C; detector voltage of 1.75 kV; DP of
80V and EP of 10V.
Preparation of Standard Solutions and Calibration
Curves
Ten mg/ml stock solutions of BAs and ISs were separately
prepared in MeOH: water (1: 1, v/v). Bile and serum were
collected from the 6 untreated mice, and bile was 100-fold
diluted using deionized water. The diluted bile and serum were
incubated with 100mg/ml activated charcoal for 1 h to strip
these matrices of endogenous BAs. Mixtures were centrifuged
at 15,000 rpm for 10min, and the supernatants were filtered.
The filtrates were used to construct the calibration curves. Fixed
volumes of these stripped matrices were spiked with 20µL of
the appropriate standard solution containing IS to construct
a calibration curve with the range of 0.05–20µg/mL, 0.01–
20µg/mL, 0.01–10µg/mL, 0.01–100µg/mL, 0.05–100µg/mL,
0.01–20µg/mL, 0.01–10µg/mL, 0.01–20µg/mL, 0.01–10µg/mL
for CA, CDCA, DCA, GCA, GCDCA, GDCA, HDCA, TCA,
UDCA, respectively. The concentration of the IS was 2µg/mL.
Sample Preparation
The blood and bile samples used in this study were collected
after the last administration. An aliquot of 300µL mixed serum
sample spiked with 30µL IS working solution, was added with
2700µL methanol-acetonitrile (1: 1, v/v), vortexed for 1min,
and centrifuged at 9000 rpm for 10min. The supernatant was
aspirated, evaporated under vacuum, and reconstituted in 300µL
of MeOH. Bile samples were diluted 100-fold with deionized
water, 100µL of diluted bile samples were spiked with 10µL
IS working solution, and then added with 900µL methanol-
acetonitrile (1: 1, v/v), after vortexed mixing for 1min, ultrasonic
extraction for 5min, and centrifugation for 10min at 9000 rpm,
The supernatant was aspirated, evaporated under vacuum, and
reconstituted in 100µL of MeOH.
Method Validation
The limit of quantification (LOQ) was defined as the lowest
concentrations with a signal-to-noise (S/N) ratio of 10:1. The
method was validated using 5 QC points for each calibration
curve. Five replicates of each QC point were analyzed repeatedly
at 3 continuous days to determine the intra- and inter-day
accuracy and precision. The concentrations of the QC points
were 0.01, 0.1, 1, 10, 100µg/mL for all BAs. Inter-day accuracy
and precision were calculated from the % bias [% (Measured—
Theoretical)/Measured concentrations] and relative standard
deviation [% RSD = % Standard Deviation/Mean], respectively,
for the 5 replicates of each QC point.
Data Processing and Statistical Analysis
All values were indicated as mean± standard deviation (mean±
SD). Differences between groups were tested by One-Way
analysis of variance (ANOVA) using SPSS 20.0. To evaluate
the indicative roles of the nine BAs, the concentration list
data obtained by the MRM was used for multivariate analysis
(PLS-DA, partial least square-discriminate analysis) using the
SIMCA-P (version 11.0), after principal component analysis
(PCA). The influence of raw HSW, processed HSW and
chlorpromazine on the metabolism of BA was summarized,




Nine BAs were simultaneously detected in rat bile and serum
by LC-MS with MRM mode. LC/MS/MS chromatograms of
the nine BAs were shown in Figure 1. The assay was validated
according to the U.S. FDA guidance on bioanalytical method
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FIGURE 1 | LC/MS/MS chromatograms of nine bile acids.
validation. To ensure the method reliability and reproducibility
for BAs analysis, 5 QC concentrations distributed throughout the
calibration range for each analyte in eachmatrix were determined
to evaluate intra-day and inter-day accuracy and precision. The
inter-day accuracy and precision for all analytes in bile were
less than 10% (Table S2 depicted in Supplementary Material).
The inter-day accuracy and precision for all analytes in serum
was less than 10% at all concentration levels (Table S3 depicted
in Supplementary Material). Good linearity was achieved over
the calibration range (r2> 0.99), and calibration curves covered
wide dynamic ranges. The LOQ for the nine BAs ranged between
10 and 50 ng/ml. Furthermore, the stability of stock solutions
under storage conditions was tested. BAs were stable for at least 1
month in the −80◦C freezer, and 10 days in the −20◦C freezer
respectively, stabilities of the analytes were proved acceptable
(Tables S4, S5 depicted in Supplementary Material).
Quantitative Analysis of Bile Acids
The amounts of the nine BAs in bile and serum (except GDCA
and TCA, which were not detected) were listed in Table 1. The
analytes were quantitatively analyzed with the method described
in the Experimental section. The concentrations of BAs in
treatment groups were compared with normal control group
by one-way analysis of variance (ANOVA) using SPSS 20.0.
Despite big variations between individuals, significant difference
was observed for BAs at specific treatment groups, as labeled in
Table 1.
Liver Injury Biomarker Analysis
This study was the further study of screening for sensitive
indicators of liver injury induced by HSW. The result of normal
serum biochemical indicators and liver histopathology has been
presented in our previous study (Tu et al., 2015). In that study, we
have got the conclusion that processing could reduce the toxicity
of HSW, andDBIL, TBIL weremore sensitive than ALT, AST, and
ALP.
To further investigate the indicative roles of the nine BAs,
the concentration list data obtained was used for PLS-DA using
the SIMCA-P (version 11.0) after PCA. The scatter plots were
shown in Figure 2 and Figure S2. It was indicated that normal
control group and raw HSW overdose treatment group were
separately clustered and could be clearly distinguished with
quantitative analysis of BAs in rat bile and serum, however,
there was cross between normal control group and processed
HSW overdose treatment group, between raw HSW overdose
treatment group and chlorpromazine treatment group in the
clusters. The result of clusters were consistent with the result of
histopathology shown in our previous study, the liver section of
normal control rats showed normal hepatocyte structure, and the
histopathology of processed HSW group rat livers was similar
to normal control group, no obvious hepatocyte necrosis was
found. Mild to moderate hepatocyte necrosis and distinct hepatic
sinusoid hyperemia occurred in rats receiving raw HSW. The
hepatocyte necrosis and hepatic sinusoid hyperemia were much
severe in rat receiving chlorpromazine (Tu et al., 2015).
In order to find characteristic biomarkers for liver injury
induced by HSW, PLS-DA was applied to investigate deep
differences between normal control group and raw HSW
overdose treatment group, processed HSW overdose treatment
group, chlorpromazine treatment group, respectively. The
variable influence on the projection (VIP) parameter was applied
to select variables that have significant contribution in clusters
between two groups, the PLS-DA plots were shown in Figure 3,
the loading plots were shown in Figure 4 and variables with
VIP > 1 were marked with blue triangles, and the results
of model validation plots were shown in Figure S3 depicted
in Supplementary Material. The PLS-DA parameters including
R2X, R2Y, Q2Y, R2-intercept and Q2-intercept were listed in
Table S6. The PLS-DA clusters between two groups showed that
normal control group and raw HSW treatment group could
be distinguished with BAs in bile and also in serum. Normal
control group and chlorpromazine treatment group could be
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TABLE 1 | Bile and serum concentrations of bile acids in normal control, processed HSW, raw HSW, and chlorpromazine treated groups.
Compounds Normal control Processed HSW Raw HSW Chlorpromazine
BILE ACID (ng/ml, mean ± SD)
CA 125050.00± 36668.08 167283.33±49153.64* 99050.00± 41540.19† 68663.33±40810.28††
CDCA 884.17± 256.17 1219.50±596.60* 475.42± 242.32†† 322.83±89.92††
DCA 380.17± 66.76 211.57±90.00† 19.55± 9.77†† 39.89±22.67††
GCA 57883333.33± 5299001.48 77400000.00±5091954.44** 55666666.67± 8155529.82 21398333.33±8946105.53††
GCDCA 523166.67± 64534.81 823833.33±147397.22* 456750.00± 90797.54 125616.67±40574.58††
GDCA 202166.67± 40341.57 213983.33±68986.23 43821.67± 20048.25†† 24390.00±13348.07††
HDCA 1260.33± 320.75 611.50±169.02† 165.62± 83.37†† 327.67±103.45††
TCA 1268333.33± 39168.44 1376666.67±26583.20* 1535000.00± 58544.85** 1593333.33±71530.88**
UDCA 221.03± 106.61 202.92±90.09† 98.32± 25.83†† 49.77±15.96††
SERUM (ng/ml, mean ± SD)
CA 2210.40± 1184.29 3227.50±1077.58 3023.50± 1407.08* 3922.50±1112.73*
CDCA 1155.85± 721.26 3017.00±1596.28 688.00± 198.72 1032.30±394.29
DCA 224.98± 98.56 173.50±56.52† 37.92± 12.81†† 81.89±27.24††
GCA 5788333.33± 264950.08 7740000.00±254597.72 5566666.67± 407776.49 2139833.33±447305.28††
GCDCA 628.00± 83.85 102.50±50.20†† 288.80± 104.17†† 358.65±82.72†
HDCA 825.25± 333.65 636.10±184.25 20.45± 7.69†† 435.00±177.86
UDCA 49.81± 15.65 96.44±36.07* 63.73± 27.12* 83.11±40.51*
**P ≤ 0.01; *P ≤ 0.05, significantly increased. ††P ≤ 0.01; †P ≤ 0.05, significantly decreased.
FIGURE 2 | PLS-DA clusters based on the quantitative analysis of BAs in rat bile and serum (n = 6) from different treatment groups in negative ESI
mode.
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FIGURE 3 | Discrimination of normal control rats from raw HSW, processed HSW and chlorpromazine treatment rats according to PLS-DA. (A–C)
Discriminations based on the quantitative analysis of BAs in rat bile. (D–F) Discriminations based on the quantitative analysis of BAs in rat serum.
FIGURE 4 | Loading plots of PLS-DA between normal control group and raw HSW overdose treatment group, processed HSW overdose treatment
group, chlorpromazine treatment group, respectively. Loading plots of PLS-DA between normal control group and raw HSW overdose treatment group based
on bile acids in rat bile (A) and rat serum (D). Loading plots of PLS-DA between normal control group and processed HSW overdose treatment group based on bile
acids in rat bile (B) and rat serum (E). Loading plots of PLS-DA between normal control group and chlorpromazine treatment group based on bile acids in rat bile (C)
and rat serum (F). Blue triangles were BAs with VIP > 1 in the model.
distinguished with BAs in bile and also in serum. There was cross
between normal control group and processed HSW treatment
with BAs in bile and also in serum. The variables with VIP >
1 in clusters between normal control group and raw HSW
treatment group were selected as potential biomarkers, as there
was no obvious liver injury in process HSW treatment group,
the variables with VIP > 1 in clusters between normal control
group and process HSW treatment group were excluded, as a
result GDCA in bile, as well as HDCA in serum were selected
as potential biomarkers for HSW induced liver injury.
Discussion
HSW is a traditional Chinese medicine, which has been used
for a long time, and was traditional regarded as non-toxic. As
far as we know, the first study focused on the toxicity of it was
reported in 1996 (But et al., 1996), and at present the detection of
it was mainly relied on the standard rules of common liver injury
detection, however, this approach has reported to have limitation
in sensitivity (Yamazaki et al., 2013). So it is urgently needed
to find new biomarkers for HSW induced liver injury diagnosis
to complement the current methodology. Synthesis, metabolism,
clearance and intestinal absorption of BAs has been reported
to enrolled in hepatic diseases (Bobeldijk et al., 2008; Alnouti,
2009), and total serum bile acid has been suggested to be sensitive
than some traditional assays for liver disease (Bouchier and
Pennington, 1978). Our previous study has showed that DBIL
and TBIL were more sensitive than ALT, AST, and ALP to liver
injury induced by HSW (Tu et al., 2015), and aqueous extracts
of HSW with high dose has reported to decrease the content
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FIGURE 5 | Bile acids metabolism in liver and intestine. The bar graphs show the differences of concentrations of BAs between four groups, and the
concentrations of BAs in normal control group were set as 1 as the control. N, P, R, and C represent the normal control, processed HSW, raw HSW and
chlorpromazine group separately. **P ≤ 0.01; *P ≤ 0.05, significantly change was observed when compared with normal control.
of TBIL in serum (Wang et al., 2012). Therefore, detection of
BAs seems to be an advisable method to detect toxicity of HSW.
Some previous research has shown that perturbation of bile acids
present in multiple models pertaining to HSW (Bechmann et al.,
2013; Péan et al., 2013; Luo et al., 2014). However, there was no
report about analysis on individual bile acids in bile or serum in
rats with liver injury induced by HSW.
In this assay, targeted analysis was developed for nine BAs that
were abundant in mammals, to search for potential biomarkers
for liver injury induced by HSW. GDCA in bile, as well as
HDCA in serum were significant decrease and were selected as
potential biomarkers for HSW induced liver injury. GDCA has
been selected as biomarker in acetaminophen-induced acute liver
failure in clinical study (Woolbright et al., 2014), Dietary HDCA
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exerted hypolipidemic effects by reducing farnesoid X receptor
antagonist bile acids in mouse enterohepatic tissues (Watanabe
and Fujita, 2014). Bile acids was synthesized in liver, and
transported from hepatocytes into the biliary tracts by canalicular
transporters, this process was sensitive to perturbation (Jaeschke
et al., 2002; Yamazaki et al., 2013), which further confirmed that
bile acids were highly sensitive markers for liver injury. Although
the mechanism behind why specific bile acid was elevated or
decreased in liver injury rats was not solved in this paper, and the
potential biomarkers needed further validation on clinical stage,
the value of examining individual BAs was emphasized, which
with a clinical studymight offer a new potential for early warning,
diagnosis and prognosis of liver injury induced by HSW.
As far as we known, present study about liver injury induced
by HSW was mostly focused on clinical case report and
hepatotoxic components in HSW (Lin et al., 2015), except for a
little in vitro assays focused on L02 cell and P450 enzyme (Unger
and Frank, 2004), there was little mechanism study of liver
injury induced by HSW. In order to provide some information
for further mechanism study of liver injury induced by HSW,
metabolism of BA was summarized, and shown in Figure 5.
BAs were derived from the catabolism of cholesterol, and BAs
pool could be divided into primary and secondary BAs based on
biological source. In the progress of primary BAs biosynthesis,
P450 enzymes including CYP7A1, CYP8B1, CYP27A1, and
CYP7B1were involved in de Aguiar Vallim et al. (2013), and there
has been literatures reporting that HSW and anthraquinones in it
would inhibit P450s involved in metabolism of pharmaceuticals
(Sridhar et al., 2012; Wang et al., 2015). However, there was
little study focusing on the influence of HSW to P450s involved
in primary BAs biosynthesis in pathogenesis of liver injury. As
present study has showed significant change of primary bile acids,
it would be meaningful to investigate the activity of related P450s
in further study. In addition, we have detected significant change
of secondary bile acids followed the ingestion of HSW. It is
known the biosynthesis of secondary bile acids is tied to gut
microorganisms (Liu et al., 2015). Nevertheless, anthraquinones,
one of the major types of components in HSW, have been
reported to own strong antibacterial effect (Njeru et al., 2015).
And anthraquinones could induce diarrhea and further alter
the gut microorganism composition (David et al., 2015; Goulet,
2015). Hence, in the further study, it would be interesting to
investigate the role of gut microorganisms played in liver injury
induced by HSW.
We acknowledge several limitations with this study. First, we
have only analyzed a limited number of BAs. It will be necessary
to validate these findings with a more extensive panel. Second,
we need to further extend the coverage of metabolites by the
untargeted metabolomic platform to assess if more sensitive DILI
biomarkers can be discovered. Third, the dose of HSW used this
study referred to HSW used in the assay of subacute toxicity
(Wu et al., 2012), equivalent to 100 times of the upper dose of
human stipulated in Chinese Pharmacopoeia (Wang et al., 2012),
and histopathology of these rats has been studied to confirm
that liver injury was appeared in raw HSW and chlorpromazine
group, however the condition was similar but not equal to clinical
condition. For the idiosyncratic hepatotoxins, more doses and
time points at a clinical stage need to be detected to establish the
clinical relevance to humans.
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